Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEMA6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DNM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF3C3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUTM2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBSCR17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G6PD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC11A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AXIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVPI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on